CL2015001768A1 - Método de evaluación de gravedad de lesión renal aguda (aki) luego de una cirugía cardiaca; y kit de diagnóstico. - Google Patents

Método de evaluación de gravedad de lesión renal aguda (aki) luego de una cirugía cardiaca; y kit de diagnóstico.

Info

Publication number
CL2015001768A1
CL2015001768A1 CL2015001768A CL2015001768A CL2015001768A1 CL 2015001768 A1 CL2015001768 A1 CL 2015001768A1 CL 2015001768 A CL2015001768 A CL 2015001768A CL 2015001768 A CL2015001768 A CL 2015001768A CL 2015001768 A1 CL2015001768 A1 CL 2015001768A1
Authority
CL
Chile
Prior art keywords
aki
severity
evaluation
diagnostic kit
acute renal
Prior art date
Application number
CL2015001768A
Other languages
English (en)
Inventor
Frank Dieterle
Holger Hoefling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2015001768A1 publication Critical patent/CL2015001768A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7275Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
CL2015001768A 2012-12-20 2015-06-19 Método de evaluación de gravedad de lesión renal aguda (aki) luego de una cirugía cardiaca; y kit de diagnóstico. CL2015001768A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261740303P 2012-12-20 2012-12-20

Publications (1)

Publication Number Publication Date
CL2015001768A1 true CL2015001768A1 (es) 2015-10-09

Family

ID=49885245

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015001768A CL2015001768A1 (es) 2012-12-20 2015-06-19 Método de evaluación de gravedad de lesión renal aguda (aki) luego de una cirugía cardiaca; y kit de diagnóstico.

Country Status (20)

Country Link
US (1) US20150309052A1 (es)
EP (1) EP2936160A1 (es)
JP (2) JP6416778B2 (es)
KR (1) KR20150096728A (es)
CN (1) CN104871004A (es)
AR (1) AR094118A1 (es)
AU (2) AU2013360685A1 (es)
BR (1) BR112015014232A2 (es)
CA (1) CA2895096A1 (es)
CL (1) CL2015001768A1 (es)
HK (1) HK1209838A1 (es)
IL (1) IL239431A0 (es)
MA (1) MA38171B1 (es)
MX (1) MX2015008108A (es)
PH (1) PH12015501399A1 (es)
RU (1) RU2015129496A (es)
SG (1) SG11201504329RA (es)
TN (1) TN2015000263A1 (es)
TW (1) TW201430347A (es)
WO (1) WO2014096110A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037043A1 (zh) * 2017-08-24 2019-02-28 菲鹏生物股份有限公司 急性肾损伤的检测试剂盒
CN108986915B (zh) * 2018-07-24 2021-07-06 戴松世 人工智能的急性肾损伤的早期预测方法和装置
WO2020064995A1 (en) * 2018-09-28 2020-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes
KR20200042725A (ko) 2018-10-16 2020-04-24 (주) 솔 렌즈 프리 cmos 광자 어레이 센서의 노이즈 특성 평가 방법
US20220301711A1 (en) * 2019-06-11 2022-09-22 The Regents Of The University Of California Systems and Methods for Machine Learning-based Identification of Acute Kidney Injury in Trauma Surgery and Burned Patients
CN110441457A (zh) * 2019-08-02 2019-11-12 深圳市绿航星际太空科技研究院 一种检测尿液中同型半胱氨酸的方法
CN112114125A (zh) * 2020-08-27 2020-12-22 中国医学科学院北京协和医院 一种评估肾脏储备功能的方法和系统及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135147D1 (de) * 2000-10-17 2008-09-11 Besst Test Aps Nen biologischen zelle in einer körperflüssigkeitsprobe
US20040048274A1 (en) * 2000-10-17 2004-03-11 Morten Breindahl Assay for directly detecting an inflammatory indicator in a body fluid sample
US20040063160A1 (en) * 2000-10-17 2004-04-01 Lassen Michael Rud Assay for directly detecting a biological cell in a body fluid sample
US20090238812A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
CN102264230B (zh) * 2008-11-10 2014-12-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
WO2010057184A2 (en) * 2008-11-17 2010-05-20 The Brigham And Women's Hospital, Inc. Methods for detection of acute kidney injury in humans
AU2009318813B2 (en) * 2008-11-21 2016-11-24 Future Medical Diagnostics Co., Ltd Methods, devices and kits for detecting or monitoring acute kidney injury
CN101706497A (zh) * 2009-11-05 2010-05-12 武汉三鹰生物技术有限公司 人tff3的elisa检测试剂盒
AU2010315008B2 (en) * 2009-11-07 2015-12-03 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2569631A4 (en) * 2010-05-10 2013-12-04 Austin Health MARKER FOR ACUTE KIDNEY INJURY
EP2661620A4 (en) * 2011-01-08 2014-07-16 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL INSUFFICIENCY

Also Published As

Publication number Publication date
AU2017232081A1 (en) 2017-10-12
MA38171B1 (fr) 2017-07-31
RU2015129496A (ru) 2017-01-26
MA38171A1 (fr) 2016-11-30
BR112015014232A2 (pt) 2017-07-11
CA2895096A1 (en) 2014-06-26
TW201430347A (zh) 2014-08-01
CN104871004A (zh) 2015-08-26
IL239431A0 (en) 2015-07-30
HK1209838A1 (en) 2016-04-08
US20150309052A1 (en) 2015-10-29
MX2015008108A (es) 2015-11-06
JP6416778B2 (ja) 2018-10-31
WO2014096110A1 (en) 2014-06-26
PH12015501399A1 (en) 2015-09-07
AU2013360685A1 (en) 2015-07-02
TN2015000263A1 (fr) 2016-10-03
SG11201504329RA (en) 2015-07-30
AR094118A1 (es) 2015-07-08
EP2936160A1 (en) 2015-10-28
KR20150096728A (ko) 2015-08-25
JP2016503162A (ja) 2016-02-01
JP2019053067A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
CL2015001768A1 (es) Método de evaluación de gravedad de lesión renal aguda (aki) luego de una cirugía cardiaca; y kit de diagnóstico.
EP3033661A4 (en) Dynamically determining risk of clinical condition
DK2720617T4 (da) Vævsbeholder / beholderaggregat og dertil knyttet fremgangsmåde.
HK1199754A1 (en) Method for monitoring, diagnosis and or prognosis of acute kidney injury in early stage
BR112013013584A2 (pt) endoscópio, e, método
EP3186397A4 (en) Use of circulating cell biomarkers in the blood for detection and diagnosis of diseases and methods of isolating them
BR112014031335A2 (pt) bloco de diagnóstico transacional
BR112014031412A2 (pt) método de preparação de uma composição, composição e seu uso, e kit.
DK2900279T3 (da) Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer
BR112014014213A2 (pt) agentes hemostáticos e método de utilização
BR112014021535A2 (pt) Material adsorvente de odor, kit de detecção de odor e seu método de uso
BR112015007861A2 (pt) prótese de tecido
FI20126266A (fi) Pehmopaperin mittaus
BR112014007007A2 (pt) método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico
CL2015000789A1 (es) Método de determinación de toxicidad mitocondrial de una sustancia de prueba.
BR112013012450A2 (pt) composições, métodos de detecção e kits
BR112014007442A2 (pt) instrumento oftalmológico, e, método
BR112014026557A2 (pt) fralda descartável.
IT1401283B1 (it) Strumento e metodo oftalmico
EP2882341A4 (en) KITS AND METHODS FOR DETERMINING THE PHYSIOLOGICAL RATE OR RATE AND / OR BEACH OR BEACHES OF HEMOGLOBIN AND / OR DISEASE CONDITION
DE102013202503A8 (de) Instrument, insbesondere medizinisch-endoskopisches Instrument oder Technoskop
DK2590565T3 (da) Blodprøvetagning
HK1206653A1 (en) Intravascular line and port cleaning methods, methods of administering an agent intravascularly, methods of obtaining testing blood, and devices for performing such methods
EP3045916A4 (en) Kit and method for diagnosis, prognosis or monitoring of liver disease through measurement of amount of ast
EP3206032A4 (en) Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure